Literature DB >> 18583538

IFATS collection: Combinatorial peptides identify alpha5beta1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells.

Jing Nie1, Benny Chang, Dmitry O Traktuev, Jessica Sun, Keith March, Lawrence Chan, E Helene Sage, Renata Pasqualini, Wadih Arap, Mikhail G Kolonin.   

Abstract

The biological features of adipose stromal (stem) cells (ASC), which serve as progenitors for differentiated cells of white adipose tissue (WAT), are still largely undefined. In an initiative to identify functional ASC surface receptors, we screened a combinatorial library for peptide ligands binding to patient-derived ASC. We demonstrate that both primary and cultured human and mouse stromal cells express a conserved receptor targeted by peptides found to mimic SPARC, a matricellular protein that is required for normal WAT development. A signaling receptor for SPARC has not as yet been determined. By using the SPARC-mimicking peptides CMLAGWIPC (termed hPep) and CWLGEWLGC (termed mPep), isolated by panning on human and mouse cells, respectively, we identified the alpha5beta1 integrin complex as a candidate receptor for SPARC. On the basis of these results, we evaluated ASC responses to SPARC or SPARC-mimicking peptide exposure. Our results suggest that extracellular SPARC binds to alpha5beta1 integrin at sites of focal adhesions, an interaction disrupting firm attachment of ASC to extracellular matrix. We propose that SPARC-mediated mobilization of ASC through its effect on alpha5beta1 integrin complex provides a functional basis for the regulation of WAT body composition by SPARC. We also show that alpha5beta1 integrin is a potential target for ASC-selective intracellular delivery of bioactive peptides and gene therapy vectors directed by the SPARC-mimicking peptides. Disclosure of potential conflicts of interest is found at the end of this article.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583538      PMCID: PMC4066418          DOI: 10.1634/stemcells.2008-0212

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  56 in total

Review 1.  SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury.

Authors:  A D Bradshaw; E H Sage
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  A hybrid vector for ligand-directed tumor targeting and molecular imaging.

Authors:  Amin Hajitou; Martin Trepel; Caroline E Lilley; Suren Soghomonyan; Mian M Alauddin; Frank C Marini; Bradley H Restel; Michael G Ozawa; Catherine A Moya; Roberto Rangel; Yan Sun; Karim Zaoui; Manfred Schmidt; Christof von Kalle; Matthew D Weitzman; Juri G Gelovani; Renata Pasqualini; Wadih Arap
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

3.  Design and construction of targeted AAVP vectors for mammalian cell transduction.

Authors:  Amin Hajitou; Roberto Rangel; Martin Trepel; Suren Soghomonyan; Juri G Gelovani; Mian M Alauddin; Renata Pasqualini; Wadih Arap
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

4.  A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks.

Authors:  Dmitry O Traktuev; Stephanie Merfeld-Clauss; Jingling Li; Mikhail Kolonin; Wadih Arap; Renata Pasqualini; Brian H Johnstone; Keith L March
Journal:  Circ Res       Date:  2007-10-25       Impact factor: 17.367

Review 5.  Adipose-derived stem cells for regenerative medicine.

Authors:  Jeffrey M Gimble; Adam J Katz; Bruce A Bunnell
Journal:  Circ Res       Date:  2007-05-11       Impact factor: 17.367

6.  Multilineage cells from human adipose tissue: implications for cell-based therapies.

Authors:  P A Zuk; M Zhu; H Mizuno; J Huang; J W Futrell; A J Katz; P Benhaim; H P Lorenz; M H Hedrick
Journal:  Tissue Eng       Date:  2001-04

7.  Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.

Authors:  R Pasqualini; E Koivunen; R Kain; J Lahdenranta; M Sakamoto; A Stryhn; R A Ashmun; L H Shapiro; W Arap; E Ruoslahti
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

8.  Expression and purification of recombinant human SPARC produced by baculovirus.

Authors:  A D Bradshaw; J A Bassuk; A Francki; E H Sage
Journal:  Mol Cell Biol Res Commun       Date:  2000-06

9.  Common deleted genes in the 5q- syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice.

Authors:  S Lehmann; J O'Kelly; S Raynaud; S E Funk; E H Sage; H P Koeffler
Journal:  Leukemia       Date:  2007-07-12       Impact factor: 11.528

10.  Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment.

Authors:  James E Ip; Yaojiong Wu; Jing Huang; Lunan Zhang; Richard E Pratt; Victor J Dzau
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

View more
  37 in total

1.  Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors.

Authors:  Ann H Klopp; Yan Zhang; Travis Solley; Felipe Amaya-Manzanares; Frank Marini; Michael Andreeff; Bisrat Debeb; Wendy Woodward; Rosemarie Schmandt; Russell Broaddus; Karen Lu; Mikhail G Kolonin
Journal:  Clin Cancer Res       Date:  2011-12-13       Impact factor: 12.531

2.  Integrin β4 regulates SPARC protein to promote invasion.

Authors:  Kristin D Gerson; Jeffrey R Shearstone; V S R Krishna Maddula; Bruce E Seligmann; Arthur M Mercurio
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

Review 3.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

4.  PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling.

Authors:  Stacey L Thomas; Ridwan Alam; Nancy Lemke; Lonni R Schultz; Jorge A Gutiérrez; Sandra A Rempel
Journal:  Neuro Oncol       Date:  2010-05-14       Impact factor: 12.300

5.  Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.

Authors:  Masaki Iwasa; Yasuo Miura; Aya Fujishiro; Sumie Fujii; Noriko Sugino; Satoshi Yoshioka; Asumi Yokota; Terutoshi Hishita; Hideyo Hirai; Akira Andoh; Tatsuo Ichinohe; Taira Maekawa
Journal:  Int J Hematol       Date:  2017-01-02       Impact factor: 2.490

6.  SPOCK1 overexpression induced by platelet-derived growth factor-BB promotes hepatic stellate cell activation and liver fibrosis through the integrin α5β1/PI3K/Akt signaling pathway.

Authors:  Zhipeng Du; Zhuoying Lin; Zhihui Wang; Danfei Liu; Dean Tian; Limin Xia
Journal:  Lab Invest       Date:  2020-04-14       Impact factor: 5.662

7.  PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma.

Authors:  Ridwan Alam; Chad R Schultz; William A Golembieski; Laila M Poisson; Sandra A Rempel
Journal:  Neuro Oncol       Date:  2013-02-03       Impact factor: 12.300

8.  Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.

Authors:  Shanna A Arnold; Lee B Rivera; Andrew F Miller; Juliet G Carbon; Sean P Dineen; Yang Xie; Diego H Castrillon; E Helene Sage; Pauli Puolakkainen; Amy D Bradshaw; Rolf A Brekken
Journal:  Dis Model Mech       Date:  2009-12-09       Impact factor: 5.758

9.  SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling.

Authors:  Jing Nie; E Helene Sage
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

10.  Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose.

Authors:  Katrina Kos; Steve Wong; Bee Tan; Anders Gummesson; Margareta Jernas; Niclas Franck; David Kerrigan; Fredrik H Nystrom; Lena M S Carlsson; Harpal S Randeva; Jonathan H Pinkney; John P H Wilding
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.